|
|
Article: Microbix And Hunan Biopharmaceutical To Build Asia's Largest Influenza Vaccine Facility.
- Article from:
- PR Newswire
- Article date:
- October 27, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Canadian Biotech Company Will Provide Its VIRUSMAX(TM) Technology That Will Double Influenza Vaccine Production
TORONTO, Oct. 27 /PRNewswire-FirstCall/ -- Microbix, (TSX:MBX) a developer of a patented technology that doubles the output of influenza vaccine production, announced today it has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. (a Hunan Province state-owned enterprise) for initial financing to construct Asia's largest influenza vaccine production facility and the third largest vaccine plant in the world.
Today's agreement forms an equal partnership joint venture to build and operate a $200-million facility, located ...